Cat. No. |
Name |
CAS No. |
Description |
KI3290 |
CO-1686 |
1374640-70-6 |
CO-1686 is a potent and mutant-selective EGFR inhibitor....
|
KI3460 |
CP-724714 |
537705-08-1 |
CP-724,714 is a selective inhibitor of epidermal growth factor 2(erbB/2) tyrosine kinase....
|
KI4279 |
CP673451 |
343787-29-1 |
....
|
KI0343 |
Crizotinib(PF-02341066) |
877399-52-5 |
Crizotinib is a potent and selective dual inhibitor of mesenchymal??pithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)....
|
KI1220 |
CUDC-101 |
1012054-59-9 |
CUDC-101 is a potent HDAC, EGFR and HER2 inhibitor with IC50 values of 4.4, 2.4, and 15.7 nM, respectively....
|
KI0095 |
CYT387 |
1056634-68-4 |
CYT387 is an ATP-competitive inhibitor of JAK1 and JAK2 with IC50 of 11 and 18 nM, respectively....
|
KI0352 |
Dasatinib |
302962-49-8 |
Dasatinib is a potent dual Src/Abl inhibitor....
|
KI0437 |
Dovitinib Dilactic acid (TKI258 Dilactic acid) |
852433-84-2 |
Dovitinib is a highly potent inhibitor of vascular endothelial growth factor receptor (VEGFR) 1, VEGFR2, VEGFR3, platelet-derived growth factor receptor (PDGFR) β, and fibroblast growth factor growth (FGFR)1, FGFR2, and FGFR3 (fibroblast growth factor receptors 1, 2, and 3)....
|
KI1057 |
E-3810 |
117976-90-6 |
E-3810 is a novel dual inhibitor of the VEGF and FGF receptors....
|
KI2658 |
E-7050 |
928037-13-2 |
E-7050 is novel small molecule inhibitor of the c-Met and VEGFR-2 tyrosine kinases....
|
KI3395 |
E7080 (Lenvatinib) |
417716-92-8 |
E7080 is an orally active inhibitor of multiple receptor tyrosine kinases, mostly for VEGFR2 (KDR)/VEGFR3 (Flt-4)....
|
KI2807 |
EMD-1214063 |
1100598-32-0 |
EMD-1214063 is a potent and selective inhibitor of c-Met....
|
KI3882 |
EPZ004777 |
1338466-77-5 |
....
|
KI0303 |
Erlotinib Hydrochloride |
183319-69-9 |
Erlotinib is a selective, orally available small-molecule inhibitor of the HER1/EGFR tyrosine kinase domain, used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer....
|
KI4041 |
Fasudil hydrochloride |
105628-07-7 |
....
|
KI2647 |
FLLL32 |
1226895-15-3 |
FLLL32 is a novel and small molecule inhibitor of the STAT3 pathway....
|
KI6095 |
FLT3-IN-1 |
1370256-78-2 |
....
|
KI0309 |
Gefitinib |
184475-35-2 |
Gefitinib, a synthetic anilinoquinazoline, directly and specificly inhibits tyrosine kinase (TK) phosphorylation on the epidermal growth factor receptor (EGFR) by competing for the ATP-binding site, which leads to suppression of the EGFR pathway (HER-kinase axis)....
|
KI3963 |
GSK1349572 |
1051375-16-6 |
....
|
KI0552 |
GSK1838705A |
1116235-97-2 |
GSK1838705A is a small-molecule IGF-IR and the insulin receptor inhibitor....
|